SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 2,027.82 |
| Enterprise Value ($M) | 1,937.86 |
| Book Value ($M) | 786.23 |
| Book Value / Share | 12.07 |
| Price / Book | 2.58 |
| NCAV ($M) | 368.87 |
| NCAV / Share | 5.66 |
| Price / NCAV | 5.50 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.28 |
| Return on Assets (ROA) | -0.28 |
| Return on Equity (ROE) | -0.34 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.49 |
| Current Ratio | 8.49 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 500.95 |
| Assets | 918.31 |
| Liabilities | 132.08 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 47.07 |
| Operating Income | -256.71 |
| Net Income | -223.86 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -194.50 |
| Cash from Investing | -404.08 |
| Cash from Financing | 608.85 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Fmr Llc | 6.80 | -13.70 | |
| 13G/A | Wellington Management Group Llp | 9.20 | 12.99 | |
| 13G/A | Vanguard Group Inc | 8.05 | 30.86 | |
| 13G/A | Avoro Capital Advisors LLC | 9.99 | 105.30 | |
| 13G/A | Price T Rowe Associates Inc /md/ | 10.30 | 10.77 | |
| 13G/A | Atlas Venture Fund X, L.P. | 6.40 | -16.00 | |
| 13D/A | Baker Bros. Advisors Lp | 9.30 | 0.06 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 93,977 | 348,767 | 26.95 | |
| 155,743 | 548,349 | 28.40 | |
| 127,512 | 442,078 | 28.84 | |
| 162,995 | 567,485 | 28.72 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KLTO – Klotho Neurosciences, Inc. | KOD – Kodiak Sciences Inc. |
| KROS – Keros Therapeutics, Inc. | LGND – Ligand Pharmaceuticals Incorporated |
| LNTH – Lantheus Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io